These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25801052)

  • 1. Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9.
    Abdollah F; Montorsi F; Briganti A
    Eur Urol; 2015 Aug; 68(2):e37-8. PubMed ID: 25801052
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9.
    Bogdanović J; Sekulić V
    Eur Urol; 2015 Aug; 68(2):e35-6. PubMed ID: 25801051
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9: Extended Lymph Node Dissection and the Will Rogers Phenomenon.
    Froehner M; Wirth MP
    Eur Urol; 2015 Jun; 67(6):e112. PubMed ID: 25282364
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Chris Parker, Matthew R. Sydes and Howard Kynaston's letter to the editor re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.
    Abdollah F; Briganti A
    Eur Urol; 2013 Nov; 64(5):e103-4. PubMed ID: 23915876
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Francesco Montorsi and Giorgio Gandaglia's letter to the editor re: Georgios Gakis, Stephen A. Boorjian, Alberto Briganti, et al. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur urol 2014;66:191-9.
    Gakis G; Stief CG
    Eur Urol; 2014 Dec; 66(6):e109-10. PubMed ID: 25204223
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Vérane Achard, Alan Dal Pra, and Thomas Zilli's Letter to the Editor re: Carlo A. Bravi, Nicola Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9.
    Bravi CA; Montorsi F; Briganti A
    Eur Urol; 2020 Dec; 78(6):e223-e224. PubMed ID: 33023772
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer.
    Lestingi JFP; Trinh QD; Coelho RF; Pontes J; Bastos DA; Nahas WC
    Eur Urol; 2021 Jun; 79(6):e184-e185. PubMed ID: 33685836
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Giorgio Gandaglia, Elio Mazzone, Armando Stabile, et al. Prostate-specific Membrane Antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study. Eur Urol.2022;82:411-18.
    Wang B; Li C; Zheng X; Yao K; Wang L
    Eur Urol; 2023 Jan; 83(1):e31-e32. PubMed ID: 36210216
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D'Amico, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.05.025: Re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.
    Parker C; Sydes MR; Kynaston H;
    Eur Urol; 2013 Nov; 64(5):e102. PubMed ID: 23953599
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9.
    Achard V; Dal Pra A; Zilli T
    Eur Urol; 2020 Dec; 78(6):e221-e222. PubMed ID: 33008661
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Jesse D. Sammon, Firas Abdollah, Anthony D'Amico, et al. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol 2015;68:756-65.
    Sammon JD; Abdollah FA; Trinh QD
    Eur Urol; 2016 Jun; 69(6):e129. PubMed ID: 26461111
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Francesco Montorsi, Nicola Fossati, Carlo A. Bravi, Giorgio Gandaglia, Nazareno Suardi, and Alberto Briganti's Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44. Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion?
    Knipper S; Maurer T
    Eur Urol; 2021 May; 79(5):e134. PubMed ID: 33579574
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2018 May; 73(5):e131-e132. PubMed ID: 29395499
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Alan Dal Pra, Stephane Supiot and Pirus Ghadjar's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2018 Feb; 73(2):e36-e37. PubMed ID: 28890246
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to the letter to the editor: RE: Preisser F, et al. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. The Prostate. 2018;1-7.
    Preisser F; Bandini M; Graefen M; Tilki D; Karakiewicz PI
    Prostate; 2018 Jun; 78(9):692. PubMed ID: 29607522
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Pascal Mouracade's Letter to the Editor re: Giorgio Gandaglia, Nicola Fossati, Armando Stabile, et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. Eur Urol 2017;72:289-92. Do the Data Violate Kaplan-Meier Assumptions?
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2017 Aug; 72(2):e31. PubMed ID: 28214034
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Alberto Briganti, Umberto Capitanio, Felix K.-H. Chun, et al. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. Eur Urol 2008;54:794-804.
    Cai T; Nesi G; Bartoletti R
    Eur Urol; 2009 Feb; 55(2):e32-3; author reply e34-5. PubMed ID: 18760527
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to E. David Crawford and Bo-Eric Persson's letter to the editor re: Giorgio Gandaglia, Maxine Sun, Jim C. Hu, et al. Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.01.026.
    Gandaglia G; Sun M; Briganti A; Karakiewicz PI
    Eur Urol; 2014 Aug; 66(2):e36-7. PubMed ID: 24746970
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Berardino De Bari, Stefano Arcangeli, and Filippo Alongi's letter to the editor re: Nazareno Suardi, Andrea Gallina, Giuliana Lista, et al. impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. Eur Urol 2014;65:546-51.
    Suardi N; Cozzarini C; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):e27-8. PubMed ID: 25281387
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Michael Froehner, Manfred P. Wirth's letter to the editor re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72.
    Hu JC
    Eur Urol; 2014 Nov; 66(5):e86. PubMed ID: 24882671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.